These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3095519)

  • 1. Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay.
    Castro-Magaña M; Angulo M; Fuentes B; Castelar ME; Cañas A; Espinoza B
    J Pediatr; 1986 Nov; 109(5):784-7. PubMed ID: 3095519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone secretion in patients with constitutional delay of growth and pubertal development.
    Lanes R; Bohorquez L; Leal V; Hernández G; Borges M; Hurtado E; Moncada G
    J Pediatr; 1986 Nov; 109(5):781-3. PubMed ID: 3772658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine accelerates growth in children with impaired growth hormone secretion.
    Pintor C; Cella SG; Corda R; Locatelli V; Puggioni R; Loche S; Müller EE
    Lancet; 1985 Jun; 1(8444):1482-5. PubMed ID: 2861413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine treatment for short stature.
    Pintor C; Cella SG; Loche S; Puggioni R; Corda R; Locatelli V; Müller EE
    Lancet; 1987 May; 1(8544):1226-30. PubMed ID: 2884368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: a pulse amplitude-modulated phenomenon.
    Loche S; Puggioni R; Fanni T; Cella SG; Müller EE; Pintor C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):426-30. PubMed ID: 2918053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-hormone releasing factor and clonidine in children with constitutional growth delay. Evidence for defective pituitary growth hormone reserve.
    Pintor C; Puggioni R; Fanni V; Cella SG; Villa A; Locatelli V; Müller EE
    J Endocrinol Invest; 1984 Jun; 7(3):253-6. PubMed ID: 6432895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial.
    Pescovitz OH; Tan E
    Lancet; 1988 Oct; 2(8616):874-7. PubMed ID: 2902319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine.
    Orio F; Padovano N; Cinquanta L; Colao A; Merola B; Longobardi S; Rossi E; Esposito V; Orio F; Lombardi G
    J Endocrinol Invest; 1995 Jan; 18(1):63-7. PubMed ID: 7759787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral clonidine: effective growth hormone releasing agent in children but not in adolescents.
    Batista MC; Arnhold IJ; Mendonça BB; D'Abronzo FH; Bloise W; Nicolau W
    J Pediatr; 1987 Oct; 111(4):564-7. PubMed ID: 3309234
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral clonidine-an effective growth hormone-releasing agent in prepubertal subjects.
    Lanes R; Hurtado E
    J Pediatr; 1982 May; 100(5):710-4. PubMed ID: 7040621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year treatment with clonidine in children with constitutional growth delay.
    Moreno Esteban B; Monereo Mejías S; Rodríguez Poyo-Guerrero P; Moreno Esteban FJ; Tresguerres JA
    J Endocrinol Invest; 1991 Feb; 14(2):75-9. PubMed ID: 2061572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children.
    Lanes R
    Am J Dis Child; 1989 Nov; 143(11):1284-6. PubMed ID: 2510497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
    Clayton PE; Shalet SM; Price DA; Addison GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):123-30. PubMed ID: 3248354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oxandrolone on the growth hormone response to growth hormone releasing hormone in children with constitutional growth delay.
    Loche S; Corda R; Lampis A; Puggioni R; Cella SG; Muller EE; Pintor C
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):195-200. PubMed ID: 3098462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonidine in the treatment of short stature: preliminary clinical experience].
    Calzolari G; Bellini M; Alboni S; Riva P; Bonati E
    G Clin Med; 1990; 71(8-9):517-20. PubMed ID: 2279627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction.
    Zadik Z; Limoni Y; Lieberman E
    Horm Res; 1991; 35(3-4):95-8. PubMed ID: 1806474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.